BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 30407764)

  • 1. Health Care Barriers to Provision of Long-Acting Reversible Contraception in Wisconsin.
    Olson EM; Kramer RD; Gibson C; Wautlet CK; Schmuhl NB; Ehrenthal DB
    WMJ; 2018 Oct; 117(4):149-155. PubMed ID: 30407764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to Recommended Practices for Provision of Long-Acting Reversible Contraception Among Providers in a Large U.S. Health Care System.
    Judge-Golden CP; Wiesenfeld HC; Chen BA; Borrero S
    J Womens Health (Larchmt); 2020 Dec; 29(12):1586-1595. PubMed ID: 32667847
    [No Abstract]   [Full Text] [Related]  

  • 3. Familiarity with Long-acting Reversible Contraceptives among Obstetrics and Gynecology, Family Medicine, and Pediatrics Residents: Results of a 2015 National Survey and Implications for Contraceptive Provision for Adolescents.
    Davis SA; Braykov NP; Lathrop E; Haddad LB
    J Pediatr Adolesc Gynecol; 2018 Feb; 31(1):40-44. PubMed ID: 28942106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementing best practices for the provision of long-acting reversible contraception: a survey of obstetrician-gynecologists.
    Castleberry NM; Stark L; Schulkin J; Grossman D
    Contraception; 2019 Aug; 100(2):123-127. PubMed ID: 30981843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are Wisconsin resident physicians trained in immediate postpartum long acting reversible contraception?
    Rivas K; Schmuhl NB; Taboada M; Godecker A; Brown H
    Contraception; 2021 Oct; 104(4):372-376. PubMed ID: 34081975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influences on Intentions to Place Long-Acting Reversible Contraceptives: A Pilot Study Comparing According to Provider Specialty in Ohio.
    Thompson CM; Broecker J; Dade M; Nottingham K
    J Pediatr Adolesc Gynecol; 2018 Oct; 31(5):509-515. PubMed ID: 29580916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obstetrician-gynecologists and contraception: long-acting reversible contraception practices and education.
    Luchowski AT; Anderson BL; Power ML; Raglan GB; Espey E; Schulkin J
    Contraception; 2014 Jun; 89(6):578-83. PubMed ID: 24656553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Society for Maternal-Fetal Medicine (SMFM) Consult Series #48: Immediate postpartum long-acting reversible contraception for women at high risk for medical complications.
    ; Vricella LK; Gawron LM; Louis JM
    Am J Obstet Gynecol; 2019 May; 220(5):B2-B12. PubMed ID: 30738885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can Pediatricians Provide Long-Acting Reversible Contraception?
    Norris AH; Pritt NM; Berlan ED
    J Pediatr Adolesc Gynecol; 2019 Feb; 32(1):39-43. PubMed ID: 30278228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How Long-Acting Reversible Contraception Knowledge, Training, and Provider Concerns Predict Referrals and Placement.
    Thompson CM; Broecker J; Dade M
    J Am Osteopath Assoc; 2019 Nov; 119(11):725-734. PubMed ID: 31657827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-acting reversible contraception knowledge, attitudes and use among HIV-infected and -uninfected women and their providers.
    Teodoro N; Fu A; Ohly NT; Shalev N; Matseoane-Peterssen D; Westhoff CL
    Contraception; 2019 Oct; 100(4):269-274. PubMed ID: 31226320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Access to long-acting reversible contraception among US publicly funded health centers.
    Bornstein M; Carter M; Zapata L; Gavin L; Moskosky S
    Contraception; 2018 May; 97(5):405-410. PubMed ID: 29253581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective, recommended, underutilized: a review of the literature on barriers to adolescent usage of long-acting reversible contraceptive methods.
    Coles CB; Shubkin CD
    Curr Opin Pediatr; 2018 Oct; 30(5):683-688. PubMed ID: 30028744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IUD services among primary care practices in New York City.
    Jacobson L; Garbers S; Helmy H; Roobol H; Kohn JE; Kavanaugh ML
    Contraception; 2016 Mar; 93(3):257-62. PubMed ID: 26569447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. US family physicians' intrauterine and implantable contraception provision: results from a national survey.
    Nisen MB; Peterson LE; Cochrane A; Rubin SE
    Contraception; 2016 May; 93(5):432-7. PubMed ID: 26776938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients and providers' knowledge, attitudes, and beliefs regarding immediate postpartum long-acting reversible contraception: a systematic review.
    Thompson EL; Vamos CA; Logan RG; Bronson EA; Detman LA; Piepenbrink R; Daley EM; Sappenfield WM
    Women Health; 2020 Feb; 60(2):179-196. PubMed ID: 31122167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Projections and opinions from 100 experts in long-acting reversible contraception.
    Foster DG; Barar R; Gould H; Gomez I; Nguyen D; Biggs MA
    Contraception; 2015 Dec; 92(6):543-52. PubMed ID: 26515195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of an Adolescent Gynecology Provider on Intrauterine Device and Subdermal Contraceptive Implant Use Among Adolescent Patients.
    Crain CL; DeFruscio AE; Shah PT; Hunt L; Yoost JL
    J Pediatr Adolesc Gynecol; 2020 Aug; 33(4):377-381. PubMed ID: 32087404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Availability of long-acting reversible contraceptives in Los Angeles County clinics through a Medicaid state plan amendment program.
    Natavio M; Blotky E; Van Horn CM; Waters C; Ihenacho U; Silverstein E; Cortessis VK; Nelson AL
    Contraception; 2018 Dec; 98(6):471-475. PubMed ID: 30076832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Review of Long-Acting Reversible Contraception Methods and Barriers to Their Use.
    Baron MM; Potter B; Schrager S
    WMJ; 2018 Oct; 117(4):156-159. PubMed ID: 30407765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.